Trastuzumab: How Long? Treatment Strategies after Failure

Abstract

By analogy with the use of hormonal therapies for metastatic breast cancer, treatment with trastuzumab has generally involved continuation until disease progression or unacceptable toxicity. Given the favourable toxicity profile of trastuzumab, most patients are treated until disease progression. There are no clinical data an the issue of the optimal… (More)
DOI: 10.1023/A:1026381126165

Topics

  • Presentations referencing similar topics